ENDLOS-TURBO PUT - BIOGEN IDEC | Market Closed - Boerse Frankfurt Warrants 01:04:53 06/06/2024 am IST | ||
| 11.63 EUR | -2.51% |
|
| Current month | -9.12% | ||
| 1 month | -14.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 05/24/05 | 11.66 | -2.26% |
| 04/24/04 | 11.93 | -2.37% |
| 03/24/03 | 12.22 | -4.75% |
| 31/24/31 | 12.83 | -3.46% |
| 30/24/30 | 13.29 | -3.20% |
Real-time Boerse Frankfurt Warrants
Last update June 06, 2024 at 01:04 am IST
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ7M6A |
| ISIN | DE000DJ7M6A5 |
| Date issued | 15/12/2023 |
| Strike | 360.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 9.412 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.29 € |
|---|---|
| Lowest since issue | 8.62 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
236.7
USD
Average target price
284.8
USD
Spread / Average Target
+20.30%
- Stock Market
- Certificates
- Certificat
